MNKD vs STAA: fair value comparison
MannKind Corporation and STAAR Surgical Company · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, STAA currently sits closer to the top of our discount ranking. MNKD carries the stronger quality grade.
| MNKD | STAA | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $3.80 | $24.34 |
| 12-month range | $2.54–$6.01 | $18.04–$29.55 |
| Sector rank | #17 of 113 Healthcare | #13 of 113 Healthcare |
| Quality grade | A | D |
| Leverage | Low | Low |
| Margin trend | Expanding | — |
| Revenue growth | High | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: MNKD fair value analysis · STAA fair value analysis